Correlation Between Dominari Holdings and PsyBio Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dominari Holdings and PsyBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dominari Holdings and PsyBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dominari Holdings and PsyBio Therapeutics Corp, you can compare the effects of market volatilities on Dominari Holdings and PsyBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dominari Holdings with a short position of PsyBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dominari Holdings and PsyBio Therapeutics.
Diversification Opportunities for Dominari Holdings and PsyBio Therapeutics
0.05 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Dominari and PsyBio is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Dominari Holdings and PsyBio Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PsyBio Therapeutics Corp and Dominari Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dominari Holdings are associated (or correlated) with PsyBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PsyBio Therapeutics Corp has no effect on the direction of Dominari Holdings i.e., Dominari Holdings and PsyBio Therapeutics go up and down completely randomly.
Pair Corralation between Dominari Holdings and PsyBio Therapeutics
Given the investment horizon of 90 days Dominari Holdings is expected to under-perform the PsyBio Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Dominari Holdings is 13.22 times less risky than PsyBio Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The PsyBio Therapeutics Corp is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 3.40 in PsyBio Therapeutics Corp on September 2, 2024 and sell it today you would lose (3.39) from holding PsyBio Therapeutics Corp or give up 99.71% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 99.8% |
Values | Daily Returns |
Dominari Holdings vs. PsyBio Therapeutics Corp
Performance |
Timeline |
Dominari Holdings |
PsyBio Therapeutics Corp |
Dominari Holdings and PsyBio Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dominari Holdings and PsyBio Therapeutics
The main advantage of trading using opposite Dominari Holdings and PsyBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dominari Holdings position performs unexpectedly, PsyBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PsyBio Therapeutics will offset losses from the drop in PsyBio Therapeutics' long position.Dominari Holdings vs. CytomX Therapeutics | Dominari Holdings vs. Instil Bio | Dominari Holdings vs. Spero Therapeutics | Dominari Holdings vs. Assembly Biosciences |
PsyBio Therapeutics vs. Rigel Pharmaceuticals | PsyBio Therapeutics vs. Geron | PsyBio Therapeutics vs. Verastem | PsyBio Therapeutics vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |